HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FSMA Supplier Verification Rule Close, But Third-Party Accreditation Stalls

This article was originally published in The Tan Sheet

Executive Summary

FDA Center for Food Safety and Applied Nutrition Director Michael Landa says rules for preventive controls for human food and the foreign supplier verification program are “in the final stages of review.” However, the rule for accreditation of third-party inspectors is stalled.

You may also be interested in...



FDA Focus On Food Safety Regulations May Delay OTC And Supplement Rules

FDA will try to eke out rules on OTC drug reviews and supplement labels in 2012 with its hands full implementing the food safety act. In the latest regulatory agenda, FDA priorities include an NPRM on foreign supplier verification and regulations to accredit third-party auditors to inspect firms across the agency’s oversight.

Former Food Safety Chief Doubts FDA Can Meet Foreign Inspection Mandate

The food safety law requires FDA to do more than 19,000 foreign food facility inspections in fiscal 2016, but former agency official David Acheson says, “It is not going to happen.” Acheson and other experts also question the logistics of the third-party auditor accreditation program the law established.

NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building

NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS124644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel